Beijing Scitop Bio-tech Co., Ltd.
SZSE:300858.SZ
19.72 (CNY) • At close October 26, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
| 2025 Q1 | 2024 Q4 | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | 2019 Q4 | 2019 Q3 | 2019 Q2 | 2019 Q1 | 2018 Q2 | 2018 Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 77.613 | 84.078 | 80.664 | 77.329 | 58.438 | 80.551 | 77.015 | 67.784 | 72.148 | 105.067 | 107.243 | 70.788 | 86.068 | 96.322 | 100.989 | 86.59 | 80.717 | 95.287 | 103.722 | 80.787 | 59.363 | 89.8 | 82.572 | 83.277 | 52.45 | 74.416 | 74.416 |
| Cost of Revenue
| 38.549 | 26.114 | 38.146 | 37.114 | 26.953 | 39.039 | 32.116 | 33.018 | 34.249 | 52.374 | 47.819 | 35.327 | 41.77 | 54.016 | 45.062 | 40.806 | 41.283 | 56.422 | 48.786 | 38.47 | 31.597 | 45.7 | 35.878 | 42.542 | 26.515 | 38.313 | 38.313 |
| Gross Profit
| 39.064 | 57.964 | 42.518 | 40.215 | 31.485 | 41.511 | 44.899 | 34.766 | 37.898 | 52.693 | 59.424 | 35.461 | 44.298 | 42.306 | 55.926 | 45.784 | 39.434 | 38.865 | 54.937 | 42.317 | 27.766 | 44.1 | 46.694 | 40.735 | 25.935 | 36.103 | 36.103 |
| Gross Profit Ratio
| 0.503 | 0.689 | 0.527 | 0.52 | 0.539 | 0.515 | 0.583 | 0.513 | 0.525 | 0.502 | 0.554 | 0.501 | 0.515 | 0.439 | 0.554 | 0.529 | 0.489 | 0.408 | 0.53 | 0.524 | 0.468 | 0.491 | 0.565 | 0.489 | 0.494 | 0.485 | 0.485 |
| Reseach & Development Expenses
| 7.884 | 12.282 | 7.988 | 7.327 | 8.009 | 8.678 | 9.572 | 8.628 | 6.494 | 5.192 | 5.894 | 3.367 | 7.636 | 5.742 | 7.713 | 7.333 | 6.362 | 4.707 | 5.083 | 4.369 | 3.414 | 6.071 | 4.087 | 2.321 | 2.274 | 3.014 | 3.014 |
| General & Administrative Expenses
| 7.196 | -11.309 | 16.042 | -1.865 | 6.321 | -12.356 | 11.255 | -2.787 | 6.401 | 11.593 | 14.952 | -4.405 | 7.489 | -9.816 | 21.498 | -3.219 | 7.317 | -8.637 | 6.743 | -2.11 | 3.951 | -8.397 | 4.932 | 3.539 | 4.576 | 4.797 | 4.797 |
| Selling & Marketing Expenses
| 7.269 | 0.583 | 13.279 | 10.463 | 5.462 | 10.856 | 6.604 | 8.751 | 7.726 | 8.464 | 6.468 | 6.795 | 5.505 | 5.821 | 7.251 | 7.11 | 4.824 | 4.852 | 6.344 | 4.122 | 2.751 | 2.527 | 5.865 | 5.024 | 3.028 | 3.124 | 3.124 |
| SG&A
| 14.465 | -10.727 | 29.321 | 14.34 | 11.999 | 17.178 | 17.86 | 5.964 | 14.127 | 20.758 | 21.42 | 2.39 | 12.994 | -3.994 | 28.749 | 3.891 | 12.142 | -3.784 | 13.087 | 2.012 | 6.702 | -5.87 | 10.797 | 8.563 | 7.604 | 8.168 | 8.168 |
| Other Expenses
| -8.618 | 26.73 | -24.439 | -0.06 | 0.003 | -0.167 | 0.003 | -0.399 | 0.002 | 0 | 0.016 | 0.003 | -1.065 | -0.234 | -0.1 | -0.097 | -0.1 | -1.384 | 0.088 | -0.983 | -2.257 | -0.136 | 0.002 | 0.028 | -0.025 | 0 | 0 |
| Operating Expenses
| 13.731 | 28.285 | 12.87 | 21.667 | 20.008 | 25.855 | 18.094 | 20.843 | 19.828 | 28.616 | 16.733 | 15.134 | 18.37 | 22.951 | 24.029 | 23.768 | 18.279 | 17.728 | 15.137 | 12.598 | 8.008 | 16.512 | 15.055 | 7.717 | 9.513 | 10.642 | 10.642 |
| Operating Income
| 25.333 | 29.679 | 29.649 | 18.548 | 11.477 | 15.656 | 33.784 | 21.796 | 23.59 | 19.516 | 45.912 | 24.785 | 29.097 | 30.63 | 41.849 | 26.29 | 25.935 | 28.205 | 40.231 | 28.915 | 20.359 | 29.54 | 32.233 | 32.897 | 16.046 | 24.249 | 24.249 |
| Operating Income Ratio
| 0.326 | 0.353 | 0.368 | 0.24 | 0.196 | 0.194 | 0.439 | 0.322 | 0.327 | 0.186 | 0.428 | 0.35 | 0.338 | 0.318 | 0.414 | 0.304 | 0.321 | 0.296 | 0.388 | 0.358 | 0.343 | 0.329 | 0.39 | 0.395 | 0.306 | 0.326 | 0.326 |
| Total Other Income Expenses Net
| 0.023 | -0.534 | -0.043 | 9.304 | 10.749 | 7.609 | 0.003 | -0.399 | 0.002 | 7.391 | 3.222 | 4.479 | 2.159 | -0.234 | 10.174 | 4.761 | 4.577 | 11.265 | 1.164 | -0.983 | -2.058 | 3.594 | 0.405 | 0.279 | -0.025 | 1.334 | 1.334 |
| Income Before Tax
| 25.356 | 29.145 | 29.605 | 27.699 | 22.265 | 24.04 | 33.787 | 21.397 | 23.592 | 26.907 | 45.928 | 24.788 | 28.032 | 30.396 | 41.749 | 26.193 | 25.835 | 26.822 | 40.32 | 27.932 | 18.103 | 29.404 | 32.235 | 32.925 | 16.021 | 25.582 | 25.582 |
| Income Before Tax Ratio
| 0.327 | 0.347 | 0.367 | 0.358 | 0.381 | 0.298 | 0.439 | 0.316 | 0.327 | 0.256 | 0.428 | 0.35 | 0.326 | 0.316 | 0.413 | 0.302 | 0.32 | 0.281 | 0.389 | 0.346 | 0.305 | 0.327 | 0.39 | 0.395 | 0.305 | 0.344 | 0.344 |
| Income Tax Expense
| 5.027 | 5.98 | 1.93 | 2.853 | 3.71 | 1.79 | 2.114 | 1.116 | 3.54 | 3.673 | 4.092 | 3.413 | 4.586 | 5.688 | 1.509 | 3.16 | 4.277 | 2.779 | 6.369 | 4.417 | 3.034 | 3.346 | 5.338 | 5.567 | 3.05 | 4.444 | 4.444 |
| Net Income
| 20.33 | 23.165 | 27.676 | 24.999 | 18.516 | 21.474 | 31.673 | 20.281 | 20.052 | 23.234 | 41.836 | 21.375 | 23.446 | 24.708 | 40.24 | 23.033 | 21.558 | 24.043 | 33.951 | 23.515 | 15.068 | 26.058 | 26.897 | 27.358 | 12.971 | 21.138 | 21.138 |
| Net Income Ratio
| 0.262 | 0.276 | 0.343 | 0.323 | 0.317 | 0.267 | 0.411 | 0.299 | 0.278 | 0.221 | 0.39 | 0.302 | 0.272 | 0.257 | 0.398 | 0.266 | 0.267 | 0.252 | 0.327 | 0.291 | 0.254 | 0.29 | 0.326 | 0.329 | 0.247 | 0.284 | 0.284 |
| EPS
| 0.08 | 0.09 | 0.11 | 0.095 | 0.07 | 0.082 | 0.12 | 0.077 | 0.076 | 0.1 | 0.19 | 0.096 | 0.11 | 0.11 | 0.18 | 0.1 | 0.1 | 0.11 | 0.17 | 0.14 | 0.089 | 0.16 | 0.16 | 0 | 0.078 | 0.13 | 0.13 |
| EPS Diluted
| 0.08 | 0.09 | 0.11 | 0.095 | 0.07 | 0.082 | 0.12 | 0.077 | 0.076 | 0.1 | 0.19 | 0.096 | 0.11 | 0.11 | 0.18 | 0.1 | 0.1 | 0.11 | 0.17 | 0.14 | 0.089 | 0.16 | 0.16 | 0 | 0.078 | 0.13 | 0.13 |
| EBITDA
| 25.496 | 29.156 | 29.618 | 33.411 | 28.16 | 29.712 | 39.399 | 26.477 | 28.446 | 23.677 | 50.643 | 29.331 | 32.575 | 36.919 | 46.303 | 29.449 | 29.091 | 23.898 | 39.8 | 28.258 | 21.217 | 29.439 | 33.939 | 34.35 | 17.423 | 24.833 | 24.833 |
| EBITDA Ratio
| 0.328 | 0.347 | 0.367 | 0.432 | 0.482 | 0.369 | 0.512 | 0.391 | 0.394 | 0.225 | 0.472 | 0.414 | 0.378 | 0.383 | 0.458 | 0.34 | 0.36 | 0.251 | 0.384 | 0.35 | 0.357 | 0.328 | 0.411 | 0.412 | 0.332 | 0.334 | 0.334 |